Analytical instruments and software for chromatography, mass spectrometry and laboratory automation
Waters Corporation
Milford, MA (US) · Geneva (CH) · Boston (US) · Paris (FR)New on Amplifa
About Waters Corporation
Waters Corporation is a US-based specialty measurement technology company headquartered in Milford, Massachusetts. The company develops and manufactures analytical instruments and software for liquid chromatography (HPLC/UPLC), mass spectrometry, thermal analysis and laboratory automation, including the Acquity UPLC systems, Xevo mass spectrometers, the Andrew+ pipetting robotics and the cloud software OneLab. In addition to instruments and software, chromatography columns, consumables, sample preparation products, services and training are offered. Customers come from biopharma and pharma, chemicals and materials science, clinical research and diagnostics, forensics, life science, food and beverages, environmental analysis as well as cannabis and hemp testing. Waters employs around 7,000 people worldwide, is directly represented in 35 countries, operates 15 manufacturing facilities and is present with products in more than 100 countries.
- Site
- 34 Maple Street, Milford, Massachusetts, USA
- Processes
- Laboratory automation (Andrew+ Pipetting Robot, Pipette+ Stand), OneLab Software (cloud software for liquid handling), Chromatography consumables, Informatics & Software, Service, Training/Education, Online shop with quotation function
- Materials
- High-Performance Liquid Chromatography, Mass Spectrometry, Thermal Analysis, Laboratory Automation, Laboratory Software
- Certificates
- CO2-Neutral Certified (Andrew Alliance), CO2-Neutral Certified
- Founded
- 1958
- Employees
- ca. 7,000
- Industries
- Biopharma and Pharma, Chemicals and Materials Science, Clinical Research and Diagnostics, Forensics, Life Science Research, Food and Beverages
- 01
Research & Development
- 02
Production of instruments and consumables
- 03
Software development (OneLab, Empower, MassLynx)
- 04
Sales via direct presence in 35 countries
- 05
Service and training
Products and Technologies
High-Performance Liquid Chromatography
Systems and columns such as Acquity UPLC, Alliance, XBridge and XTerra for chromatographic separations in pharma and research.
Mass Spectrometry
Xevo and Synapt systems for quantitative and structural analysis, established since 1996 through the Micromass acquisition.
Thermal Analysis
TA Instruments product line for material characterization.
Laboratory Automation
Andrew+ pipetting robot, Pipette+ Stand and connected devices for automated liquid handling workflows.
Laboratory Software
OneLab cloud platform as well as Empower (chromatography) and MassLynx (mass spectrometry) with audit trails and 21 CFR Part 11 support.
Locations
Milford, MA
USHeadquarters
Geneva
CHAndrew Alliance site (laboratory automation)
Boston
USAndrew Alliance site (laboratory automation)
Paris
FRAndrew Alliance site (laboratory automation)
Industries
Additional services
Reference customers
Quality and Certifications
Andrew Alliance is certified as a CO2 Neutral Certified Company; for the OneLab software platform, audit trails, electronic signatures and role-based access are stated to support regulatory compliance (21 CFR Part 11, EU Annex 11).
| Evidence | Geneva |
|---|---|
| CO2-Neutral Certified |
History
- 1958
James Waters founds Waters Associates in Framingham, Massachusetts
- 1963
First gel permeation chromatography instruments, among others sold to Dow Chemical
- 1967
Introduction of the first LC system ALC 100
- 1973
Relocation of headquarters to Milford, MA; initial public offering
- 1980
Millipore acquires Waters for USD 167 million
- 1994
Management-led buyout for USD 360 million; Douglas A. Berthiaume becomes CEO
- 1995
Second initial public offering
- 1996
Acquisition of TA Instruments and Micromass (entry into mass spectrometry)
- 2004
Introduction of the Acquity UPLC system
- 2006
Acquisition of Vicam
- 2017
Partnership with Andrew Alliance for laboratory automation
- 2020
Acquisition of Andrew Alliance for USD 77.4 million; Udit Batra becomes President & CEO
- 2023
Acquisition of Wyatt Technology for USD 1.36 billion
- 2025
Agreement to merge with the Biosciences & Diagnostics unit of Becton Dickinson
- 2026
Completion of the merger with the BD Biosciences & Diagnostic Solutions unit (February 9, 2026)